David Daikh, MD

Title(s)Professor Emeritus, Medicine
SchoolSchool of Medicine
AddressLocation Required, #001
Phone415-750-2104 ext. 3387
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Oregon Health Sciences University, Portland, ORMD6/1991Medicine
    Oregon Health Sciences University, Portland, ORPhD6/1991Biochemistry and Molecular Biology
    University of California, San Francisco, San Francisco, CAResidency6/1994Internal Medicine
    University of California, San Francisco, San Francisco, CAFellowship6/1997Rheumatology
    University of California, San Francisco, CA2018Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 
    Collapse Overview
    Dr. Daikh is the Rheumatology Division Chief at the SFVA Medical Center, and director of the rheumatology fellowship program at UCSF. Dr. Daikh is a UCSF Department of Medicine Master Clinician and a member of the UCSF Academy of Medical Educators. Dr. Daikh’s research has focused on immune mechanisms of rheumatic disease and novel approaches to immunotherapy. Dr. Daikh is a past president of the Rheumatology Research Foundation and is the Immediate Past President of the American College of Rheumatology.

    Collapse Research 
    Collapse Research Activities and Funding
    A Controlled Trial of CBT for Multiple Sclerosis Inflammation
    NIH R01HD043323Sep 1, 2003 - Jun 30, 2011
    Role: Principal Investigator
    T CELL COST IMMULATION ON MURINE LUPUS
    NIH K08AI001520Sep 1, 1997 - Aug 31, 2003
    Role: Principal Investigator
    Academic Rheumatology and Clinical Immunology
    NIH T32AR007304Jul 1, 1978 - Apr 30, 2019
    Role: Principal Investigator
    MULTIPURPOSE ARTHRITIS AND MUSCULOSKELETAL DISEASES CTR
    NIH P60AR020684Sep 15, 1977 - Dec 31, 2003
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Diagnosing rheumatoid arthritis: challenges and opportunities. Best Pract Res Clin Rheumatol. 2022 03; 36(1):101743. Maharaj AB, Daikh DI. PMID: 35260335.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Rheumatoid arthritis: Evolving recognition of a common disease. Best Pract Res Clin Rheumatol. 2022 03; 36(1):101740. Daikh DI. PMID: 35249826.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    3. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Ann Rheum Dis. 2021 06; 80(6):775-781. Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR. PMID: 33568386.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    4. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Ann Rheum Dis. 2020 10; 79(10):1333-1339. Johnson SR, Brinks R, Costenbader KH, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger WB, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Aringer M. PMID: 32816709.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    5. Antinuclear Antibodies and Lupus: Label Versus Meaning. Arthritis Care Res (Hoboken). 2019 11; 71(11):1401-1403. Daikh DI. PMID: 31058455.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 09; 71(9):1400-1412. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. PMID: 31385462; PMCID: PMC6827566.
      View in: PubMed   Mentions: 618     Fields:    Translation:Humans
    7. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 09; 78(9):1151-1159. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Fernández Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Dörner T, Johnson SR. PMID: 31383717.
      View in: PubMed   Mentions: 413     Fields:    Translation:Humans
    8. How Should We Consider Lupus Without Antinuclear Antibodies? Arthritis Care Res (Hoboken). 2019 07; 71(7):853-854. Daikh DI, Aringer M. PMID: 30035362.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. ACR Presidential Address: Building on the Strengths of Our Unique Specialty. Arthritis Rheumatol. 2019 05; 71(5):664-669. Daikh DI. PMID: 30698363.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019 05; 78(5):634-640. Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dörner T, Diamond B, Jacobsen S, Jayne D, Kamen DL, McCune WJ, Mosca M, Ramsey-Goldman R, Ruiz-Irastorza G, Schneider M, Urowitz M, Wofsy D, Smolen JS, Naden RP, Aringer M, Costenbader KH. PMID: 30692164; PMCID: PMC7057251.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    11. Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria. J Rheumatol. 2019 07; 46(7):721-726. Johnson SR, Khanna D, Daikh D, Cervera R, Costedoat-Chalumeau N, Gladman DD, Hahn BH, Hiepe F, Sánchez-Guerrero J, Massarotti E, Boumpas DT, Costenbader KH, Jayne D, Dörner T, Kamen DL, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Aringer M. PMID: 30554156.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    12. Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018 10; 70(10):1488-1494. Schmajuk G, Hoyer BF, Aringer M, Johnson SR, Daikh DI, Dörner T, SLE classification criteria steering committee and the international SLE expert panel of the initiat. PMID: 29287313; PMCID: PMC6026087.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    13. Early symptoms of systemic lupus erythematosus (SLE) recalled by 339 SLE patients. Lupus. 2018 Aug; 27(9):1431-1436. Leuchten N, Milke B, Winkler-Rohlfing B, Daikh D, Dörner T, Johnson SR, Aringer M, ; on behalf of the SLE Classification Criteria Steering Committee. PMID: 29771193.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    14. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Ann Rheum Dis. 2018 06; 77(6):829-832. van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S. PMID: 29525777.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    15. Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR). Arthritis Rheumatol. 2018 06; 70(6):826-831. van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S. PMID: 29532625.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    16. Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration. Arthritis Care Res (Hoboken). 2018 04; 70(4):571-581. Tedeschi SK, Johnson SR, Boumpas D, Daikh D, Dörner T, Jayne D, Kamen D, Lerstrøm K, Mosca M, Ramsey-Goldman R, Sinnette C, Wofsy D, Smolen JS, Naden RP, Aringer M, Costenbader KH. PMID: 28692774; PMCID: PMC5996759.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    17. Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data. Arthritis Care Res (Hoboken). 2018 03; 70(3):428-438. Leuchten N, Hoyer A, Brinks R, Schoels M, Schneider M, Smolen J, Johnson SR, Daikh D, Dörner T, Aringer M, Bertsias G, Systemic Lupus Erythematosus Classification Criteria Steering Committee. PMID: 28544593.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    18. How Do We Classify "Incomplete Lupus?" Arthritis Care Res (Hoboken). 2017 12; 69(12):1777-1779. Daikh DI, Costenbader KH. PMID: 28118516.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate. PLoS One. 2016; 11(12):e0168369. Schmajuk G, Tonner C, Miao Y, Yazdany J, Gannon J, Boscardin WJ, Daikh DI, Steinman MA. PMID: 27977768; PMCID: PMC5158188.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus. Cytokine. 2017 02; 90:109-112. Andrews JS, Trupin L, Hough CL, Daikh DI, Yelin EH, Katz PP. PMID: 27863333; PMCID: PMC5415383.
      View in: PubMed   Mentions: 4  Translation:HumansCTClinical Trials
    21. Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic. BMC Health Serv Res. 2016 08 15; 16(a):384. Bays A, Wahl E, Daikh DI, Yazdany J, Schmajuk G. PMID: 27527720; PMCID: PMC4986364.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. Advances in managing ankylosing spondylitis. F1000Prime Rep. 2014; 6:78. Daikh DI, Chen PP. PMID: 25343035; PMCID: PMC4166936.
      View in: PubMed   Mentions: 15  
    23. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res (Hoboken). 2014 Aug; 66(8):1159-66. Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh DI, Steinman MA. PMID: 24470205; PMCID: PMC4112168.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    24. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Arthritis Care Res (Hoboken). 2013 Mar; 65(3):329-39. Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C, American College of Rheumatology Core Membership Group. PMID: 23436818; PMCID: PMC4106486.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    25. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology. 2012 Jul 31; 79(5):412-9. Mohr DC, Lovera J, Brown T, Cohen B, Neylan T, Henry R, Siddique J, Jin L, Daikh D, Pelletier D. PMID: 22786596; PMCID: PMC3405245.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    26. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 Jun; 64(6):797-808. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM, American College of Rheumatology. PMID: 22556106; PMCID: PMC3437757.
      View in: PubMed   Mentions: 448     Fields:    Translation:HumansPHPublic Health
    27. Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road. Arthritis Care Res (Hoboken). 2012 May; 64(5):648-51. Daikh DI, St Clair EW. PMID: 22473919; PMCID: PMC4097090.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Rheumatic manifestations of cancer. Rheum Dis Clin North Am. 2011 Nov; 37(4):489-505. Ashouri JF, Daikh DI. PMID: 22075194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Resolution of recurrent fusarium arthritis after prolonged antifungal therapy. J Clin Rheumatol. 2011 Jan; 17(1):44-5. Charles JF, Eberle C, Daikh DI, Rooney T. PMID: 21169847.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    30. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells. PLoS One. 2009 Jun 24; 4(6):e6031. Scalapino KJ, Daikh DI. PMID: 19551149; PMCID: PMC2696596.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    31. B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency. J Exp Med. 2008 Nov 24; 205(12):2755-61. Gupta VA, Hermiston ML, Cassafer G, Daikh DI, Weiss A. PMID: 19001138; PMCID: PMC2585841.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    32. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev. 2008 Jun; 223:143-55. Scalapino KJ, Daikh DI. PMID: 18613834.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    33. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 2008 May; 58(5):1433-44. Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, Chang B, Zhao FF, Payan DG, Grossbard EB, Daikh DI. PMID: 18438845.
      View in: PubMed   Mentions: 65     Fields:    Translation:Animals
    34. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007 Oct 01; 176(7):691-7. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE. PMID: 17556720; PMCID: PMC1994238.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    35. Novel model of antigen-specific induction of bile duct injury. Gastroenterology. 2006 Dec; 131(6):1899-906. Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters MG. PMID: 17087941; PMCID: PMC4113411.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    36. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol. 2006 Aug 01; 177(3):1451-9. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh DI. PMID: 16849451.
      View in: PubMed   Mentions: 116     Fields:    Translation:AnimalsCells
    37. Inhibition of T cell costimulation: an emerging therapeutic strategy for autoimmune rheumatic diseases. Arthritis Rheum. 2006 Apr 15; 55(2):322-4. Daikh DI, Gillis J, Wofsy D. PMID: 16583382.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    38. The Vioxx debacle revisited. Am J Med. 2005 Sep; 118(9):1057. Daikh DI. PMID: 16164908.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Block and tackle: CTLA4Ig takes on lupus. Lupus. 2005; 14(3):197-203. Davidson A, Diamond B, Wofsy D, Daikh D. PMID: 15807196.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    40. Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide. Arthritis Rheum. 2004 May; 50(5):1539-48. Cunnane G, Chan OT, Cassafer G, Brindis S, Kaufman E, Yen TS, Daikh DI. PMID: 15146424.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    41. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002 Aug; 47(4):445-9. Cunnane G, Warnock M, Fye KH, Daikh DI. PMID: 12209493.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    42. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ. 2002 Jun 22; 324(7352):1488-92. Schumacher HR, Boice JA, Daikh DI, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. PMID: 12077033; PMCID: PMC116444.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    43. Treatment of autoimmune diseases by inhibition of T-cell costimulation. Mod Rheumatol. 2002 Mar; 12(1):1-4. Wofsy D, Daikh DI. PMID: 24383824.
      View in: PubMed   Mentions:    Fields:    
    44. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J Immunol. 2001 Mar 01; 166(5):2913-6. Daikh DI, Wofsy D. PMID: 11207238.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    45. Treatment of autoimmunity by inhibition of T cell costimulation. Adv Exp Med Biol. 2001; 490:113-7. Daikh DI, Wofsy D. PMID: 11505969.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    46. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 2000 Dec 22; 103(7):1059-70. Majeti R, Xu Z, Parslow TG, Olson JL, Daikh DI, Killeen N, Weiss A. PMID: 11163182.
      View in: PubMed   Mentions: 64     Fields:    Translation:AnimalsCells
    47. Effects of anti-B7 monoclonal antibodies on humoral immune responses. J Autoimmun. 1999 Mar; 12(2):101-8. Daikh DI, Wofsy D. PMID: 10047430.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    48. On the horizon: clinical trials of new immunosuppressive strategies for autoimmune diseases. Transplant Proc. 1998 Dec; 30(8):4027-8. Daikh DI, Wofsy D. PMID: 9865285.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    49. Opportunities for future biological therapy in SLE. Baillieres Clin Rheumatol. 1998 Aug; 12(3):529-41. Wofsy D, Daikh DI. PMID: 9890111.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    50. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol. 1997 Oct 01; 159(7):3104-8. Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D. PMID: 9317105.
      View in: PubMed   Mentions: 50     Fields:    Translation:Animals
    51. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J Leukoc Biol. 1997 Aug; 62(2):156-62. Daikh D, Wofsy D, Imboden JB. PMID: 9261329.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    David's Networks
    Concepts (232)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (37)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.